You are here

  • Home
  • Archive
  • Volume 27, Issue Suppl 1
  • 4CPS-187 Prognostic value of haematological inflammatory markers in patients with metastatic non-small cell lung cancer treated with pembrolizumab

Article info

Article menu

Download PDFPDF

Section 4: Clinical Pharmacy Services
4CPS-187 Prognostic value of haematological inflammatory markers in patients with metastatic non-small cell lung cancer treated with pembrolizumab
Free

Authors

Citation

Jimenez-Galan R, Abdel-Kader-Martin L, Mejias Trueba M, et al
4CPS-187 Prognostic value of haematological inflammatory markers in patients with metastatic non-small cell lung cancer treated with pembrolizumab
European Journal of Hospital Pharmacy 2020;27:A136.

Publication history

  • First published March 24, 2020.
Online issue publication 
August 05, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.